糖尿病是一種複雜的全身慢性疾病，需要有良好的照護品質來預防各種急慢性併發症的發生。本研究針對糖尿病健康促進機構的盡責度與照護結果進行調查，以作為改善照護品質的參考。此為一項針對糖尿病病人，非介入性的流行病學調查，本研究在台灣40家糖尿病健康促進機構進行。每家機構依據糖尿病診治個案數比率分配，收案50人到250人。符合收案條件的共有5851人，其中第1型糖尿病114位、第2型糖尿病5720位及其他型糖尿病17位。糖尿病照護盡責度完成率方面，2018年在年度糖化血色素(A1C)完整追蹤率(94.2%)、年度微量白蛋白檢查率(97.5%)、年度完整血脂檢查率(88.0%)、年度眼睛視網膜檢查率(88.8%)及年度足部檢查率(90.6%)上皆比2006年與2011年時的調查上升。重要指標達成率方面，A1C<7%的達標率(44.1%)與低密度膽固醇<100mg/dL(70.9%)的達標率皆比2006年與2011年時的調查進步，血壓<130/80mmHg的達標率則由2011年時的37.7%小幅下降到36.3%。台灣的糖尿病照護在盡責度與重要治療目標上大多有持續明顯的進步，讓病人的照護品質能夠不斷提升。

Regular waves of surveys are conducted in Taiwan in order to evaluate the quality of diabetes care among accredited Diabetes Health Promotion Institutes. Methods of study: This survey was conducted in 40 Diabetes Health Promotion Institutes in 2018. Diabetes subjects who regularly visited the same institute for at least 1 year were selected by one per every 5 consecutive visits. A total of 5,851 subjects participated in this survey. The percentage of subjects whose HbA1c < 7%, BP< 130/80 mmHg and LDL cholesterol<100 mg/dL were 44.1%, 36.3% and 70.9%, respectively. Accountabilities examination revealed that annular tests of HbA1c (≥ 3 times/year), urinary albumin, lipids, eye examination, and foot evaluation were 94.2%, 97.5%, 88.0%, 88.8%, and 90.6%, respectively. Most of these results are better than the last two surveys. We observed an improvement in overall attainments of treatment goals and accountabilities of diabetes care in Taiwan. We anticipate that these improvements will translate into reductions of both macrovascular and microvascular complications.